Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Molecular subtype combined with peripheral blast clearance rate to optimize the treatment of newly diagnosed Acute Myeloid Leukemia: Interim analysis of the multicenter, Phase II study (IA+X 2024)

Yunxiang Zhang, Hongming Zhu, Xiangqin Weng, Yongmei Zhu, Jiong Hu, Xiaoxia Hu, Qiusheng Chen, Ligen Liu, Junmin Li, Yang Shen

Blood (2025) 146 (Supplement 1): 3436.

https://doi.org/10.1182/blood-2025-3436

Published: 2025

Journal Articles

Adult acute myeloid leukemia with NUP98 rearrangement benefits from targeted therapy and bone marrow transplantation

Blood (2025) 146 (Supplement 1): 3391.

https://doi.org/10.1182/blood-2025-3391

Published: 2025

Journal Articles

Orelabrutinib plus bendamustine-rituximab (OBR) Versus Bendamustine-rituximab (BR) in transplant-ineligible, intermediate- to high-risk Mantle Cell Lymphoma (MCL)

Li Wang, Jianzhen Shen, Yaohui Huang, Jing Bao, Lin Shen, Pengpeng Xu, Shu Cheng, Hongming Zhu, Weili Zhao

Blood (2025) 146 (Supplement 1): 3599.

https://doi.org/10.1182/blood-2025-3599

Published: 2025

Journal Articles

Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: A multi-center study in China

Ya-nan Ma, Wenzhi CAI, Hongming Zhu, Ying Lu, Xiaofei Yang, Jian-xin Guo, Depei Wu, Suning Chen

Blood (2025) 146 (Supplement 1): 7347.

https://doi.org/10.1182/blood-2025-7347

Published: 2025

Journal Articles

Characteristics and clinical outcomes of ND-AML patients with bcor/bcorl1 mutations

Blood (2025) 146 (Supplement 1): 7005.

https://doi.org/10.1182/blood-2025-7005

Published: 2025

Journal Articles

Ruxolitinib combined with dexamethasone is a promising prophylaxis method for differentiation syndrome in acute promyelocytic leukemia (APL2022)

Hongming Zhu, Yubing Zhao, Xiaojing Lin, Li Chen, Fangyi Dong, Jiong Hu, Junmin Li, Yang Shen

Blood (2025) 146 (Supplement 1): 5214.

https://doi.org/10.1182/blood-2025-5214

Published: 2025

Journal Articles

NRAS mutation drives excessive netosis and differentiation syndrome in acute promyelocytic leukemia

Xiaojing Lin, Yuncan Cao, Wenjing Shu, Jiong Hu, Hongming Zhu, Yang Shen

Blood (2025) 146 (Supplement 1): 3472.

https://doi.org/10.1182/blood-2025-3472

Published: 2025

Journal Articles

Arsenic Trioxide Combined with Mannitol for the Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia Patients：a Retrospective Study

Yubing Zhao, Zhanyun Liu, Yang Shen, Jiong Hu, Junmin Li, Hongming Zhu

Blood (2024) 144 (Supplement 1): 6064.

https://doi.org/10.1182/blood-2024-200772

Published: 2024

Journal Articles

Idarubicin Plus Azacitidine + Venetoclax As Induction Therapy Achieved High Remission in Elderly Fit- Acute Myeloid Leukemia Patients: Preliminary Results of a Phase II Study

Xinjie Chen, Diyaer Abuduaini, Hongming Zhu, Jun Long, Jiong Hu, Wen Wu, Yang Shen

Blood (2023) 142 (Supplement 1): 1527.

https://doi.org/10.1182/blood-2023-180049

Published: 2023

Journal Articles

Clinical Characteristics, Genetic Profile and Prognosis of Adult Acute Myeloid Leukemia with NUP98 Rearrangement

Hongming Zhu, Yubing Zhao, Wenyan Cheng, Xinjie Chen, Yunxiang Zhang, Jiong Hu, Junmin Li, Yang Shen

Blood (2023) 142 (Supplement 1): 2867.

https://doi.org/10.1182/blood-2023-178329

Published: 2023

Journal Articles

Recommendations on Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Combination of All- Trans Retinoic Acid and Arsenic Trioxide

Blood (2023) 142 (Supplement 1): 2946.

https://doi.org/10.1182/blood-2023-184433

Published: 2023

Journal Articles

Modified Intensive Induction Treatment for Elderly Acute Myeloid Leukemia Patients Based on Peripheral Blast Clearance Rate: A Phase II Single-Arm Study

Ya Li, Xiaoyang Li, Hongming Zhu, Yunxiang Zhang, Yu Chen, Qiusheng Chen, Yu Zheng, Junmin Li

Blood (2021) 138 (Supplement 1): 1260.

https://doi.org/10.1182/blood-2021-152042

Published: 2021

Journal Articles

Retinoic Acid and Arsenic Trioxide with or without Chemotherapy for Acute Promyelocytie Leukemia with Different Risk Stratifications: A Interim Analysis of China APL 2012 Study

Blood (2016) 128 (22): 445.

https://doi.org/10.1182/blood.V128.22.445.445

Published: 2016

Journal Articles

The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia

Blood (2016) 128 (11): 1525–1528.

https://doi.org/10.1182/blood-2016-02-699439

Published: 2016

Includes: Supplemental data

Journal Articles

The Glasgow Prognostic Score (GPS) As a Significant Predictor of Diffuse Large B Cell Lymphoma Treated with the R-CHOP in China

Xiaoyang Li, Yunxiang Zhang, Hongming Zhu, Jiong Hu, Junmin Li, MD PhD

Blood (2014) 124 (21): 5398.

https://doi.org/10.1182/blood.V124.21.5398.5398

Published: 2014

Journal Articles

Long-Term Follow-up of Survival, Complications, Arsenic Retention and Quality of Life in Patients with Newly Diagnosed Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid/Arsenic Trioxide Combination Therapy

Hongming Zhu, Jiong Hu, Li Chen, Wei Zhou, Xiaoyang Li, Wang Lining, Xia Zhao, Yunxiang Zhang, Huijin Zhao, Yu Chen, Huiping Sun, Qiusheng Chen, Yu Chen, Weili Zhao, Jianqing Mi, Zhixiang Shen, Saijuan Chen, Zhenyi Wang, Junmin Li, MD PhD

Blood (2014) 124 (21): 282.

https://doi.org/10.1182/blood.V124.21.282.282

Published: 2014

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Molecular subtype combined with peripheral blast clearance rate to optimize the treatment of newly diagnosed Acute Myeloid Leukemia: Interim analysis of the multicenter, Phase II study (IA+X 2024)

Adult acute myeloid leukemia with NUP98 rearrangement benefits from targeted therapy and bone marrow transplantation

Orelabrutinib plus bendamustine-rituximab (OBR) Versus Bendamustine-rituximab (BR) in transplant-ineligible, intermediate- to high-risk Mantle Cell Lymphoma (MCL)

Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: A multi-center study in China

Characteristics and clinical outcomes of ND-AML patients with bcor/bcorl1 mutations

Ruxolitinib combined with dexamethasone is a promising prophylaxis method for differentiation syndrome in acute promyelocytic leukemia (APL2022)

NRAS mutation drives excessive netosis and differentiation syndrome in acute promyelocytic leukemia

Arsenic Trioxide Combined with Mannitol for the Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia Patients：a Retrospective Study

Idarubicin Plus Azacitidine + Venetoclax As Induction Therapy Achieved High Remission in Elderly Fit- Acute Myeloid Leukemia Patients: Preliminary Results of a Phase II Study

Clinical Characteristics, Genetic Profile and Prognosis of Adult Acute Myeloid Leukemia with NUP98 Rearrangement

Recommendations on Minimal Residual Disease Monitoring in Acute Promyelocytic Leukemia Treated with Combination of All- Trans Retinoic Acid and Arsenic Trioxide

Modified Intensive Induction Treatment for Elderly Acute Myeloid Leukemia Patients Based on Peripheral Blast Clearance Rate: A Phase II Single-Arm Study

Retinoic Acid and Arsenic Trioxide with or without Chemotherapy for Acute Promyelocytie Leukemia with Different Risk Stratifications: A Interim Analysis of China APL 2012 Study

The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia

The Glasgow Prognostic Score (GPS) As a Significant Predictor of Diffuse Large B Cell Lymphoma Treated with the R-CHOP in China

Long-Term Follow-up of Survival, Complications, Arsenic Retention and Quality of Life in Patients with Newly Diagnosed Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid/Arsenic Trioxide Combination Therapy

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only